Incyte | Marktkapitalisierung



Market Capitalization Veränderung Datum
Acadia Pharmaceuticals USD 3.05B 502M 2024-12
Agios Pharmaceuticals USD 1.87B 654M 2024-12
Amgen USD 139.96B 33.39B 2024-12
Biogen USD 22.28B 5.95B 2024-12
BioMarin Pharmaceutical USD 12.54B 855M 2024-12
Bristol-Myers Squibb USD 114.71B 9.82B 2024-12
Eli Lilly USD 732.87B 109.15B 2024-12
Gilead Sciences USD 115.09B 10.63B 2024-12
Incyte USD 13.31B 575M 2024-12
Ionis Pharmaceuticals USD 5.52B 791M 2024-12
Merck USD 251.65B 36.21B 2024-12
Moderna USD 16B 9.69B 2024-12
Neurocrine Biosciences USD 13.82B 2.18B 2024-12
Novartis CHF 194.25B 18.5B 2024-12
Pfizer USD 150.34B 13.65B 2024-12
PTC Therapeutics USD 3.51B 653M 2024-12
Regeneron Pharmaceuticals USD 78.28B 37.61B 2024-12
Sarepta Therapeutics USD 11.78B 128M 2024-12
Ultragenyx Pharmaceutical USD 3.88B 1.24B 2024-12
Vertex Pharmaceuticals USD 103.45B 16.4B 2024-12



Incyte Marktkapitalisierung - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Apr 2025.